JCI Insight is a peer-reviewed journal dedicated to biomedical research, ranging from preclinical to clinical studies.

JCI Insight publishes well-executed, high-quality, insightful research in all biomedical specialties, including Autoimmunity, Gastroenterology, Immunology, Metabolism, Nephrology, Neuroscience, Oncology, Pulmonology, Vascular Biology, and many others.

Papers submitted to JCI Insight should present a focused line of investigation that provides meaningful and impactful contributions to the understanding of the biology of disease or new therapeutic opportunities. JCI Insight articles may build on existing paradigms in the field or provide hypothesis-generating findings (see editorial). Examples of studies suitable for JCI Insight include, but are not limited to, human genetics research, new mouse models of disease, in vivo studies of disease mechanisms, precision medicine, clinical and biomarker studies, and studies that provide new resources for the biomedical research community. Studies should include a relevant in vivo model system and/or a primary human cell or tissue model.

JCI Insight builds on the editorial leadership of the JCI, one of the oldest and most respected biomedical research journals, and is published by the American Society for Clinical Investigation (ASCI), a nonprofit honor organization of physician-scientists incorporated in 1908. JCI Insight serves to fulfill the ASCI’s objective to advance medical science through the publication of clinically relevant research reports. All articles published in JCI Insight are freely available online from the moment of publication.

Submit your work to JCI Insight

• JCI Insight welcomes submissions in the following categories: Research, Technical Advance, and Clinical Medicine. You can use the journal’s submission site by accessing your existing JCI author account or signing up for a new account.
• Start your submission by accessing your author account. If you don’t have an account yet, sign up here.
• If you receive an invitation to transfer your submission from JCI to JCI Insight, the email will include a link to a web page where you can accept or decline the invitation. The invitation to transfer your manuscript to JCI Insight will remain open for 60 days. For more information about the transfer process, click here.
• Click here for information on submission, manuscript and figure preparation, and editorial policies.
• Information on publication costs, copyright information, and article availability is provided here.

Open access

All research is available to the public for free. JCI Insight deposits published research articles in PubMed Central, which satisfies the NIH Public Access Policy and other similar funding agency requirements.

Questions about submissions under consideration?

• For any communication with us, please reference the tracking number assigned by the JCI Insight noted in the acknowledgment of your submission. If you do not have this information, reference the manuscript title and corresponding author name. Send e-mail to staff@insight.jci.org or call 734-222-6050.
• To avoid confusion regarding correspondence, inquiries, and decisions, the JCI Insight will typically communicate only with corresponding authors of submissions.

Editors

JCI Insight is headed by Editor in Chief Dr. Howard Rockman, and manuscripts are adjudicated by our team of academic and professional editors. More information about the editors can be found here. In addition, the editors may seek the advice of members of our consulting editorial board.

Impact Factor information

ISSN 2379-3708